Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
+16.96%
Latest
+16.96%
3 months
Pareto SecuritiesBryan GarnierDanske BankCarnegieDanske Bank Markets

Price Targets

Latest price targets per analyst.

AnalystPrice TargetDateUpside
Pareto Securities300 SEKApr 1
+16.96%
Bryan Garnier400 SEKFeb 2
Danske Bank423 SEKOct -21
Carnegie450 SEKOct -21
Danske Bank Markets448 SEKJun -21

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion